Back to Exploring

CreditAccess Grameen Ltd: India's Largest Microfinance Institution - Deep-Dive Equity Research

company
By NiftyBrief Research TeamJune 1, 202620 min read

CreditAccess Grameen Ltd: India's Largest Microfinance Institution — A Deep-Dive Equity Research Report

Company Overview

CreditAccess Grameen Ltd (NSE: CREDITACC | BSE: 541770) is India's largest microfinance institution by loan book size, operating as a non-deposit accepting NBFC-MFI registered with the Reserve Bank of India. The company provides microfinance services to women enrolled as members and organized as Joint Liability Groups (JLGs), primarily serving low-income households in rural and semi-urban India. It also leverages its extensive distribution channel to offer other financial products and services to its member base.

Headquartered in Bengaluru, Karnataka, CreditAccess Grameen is a subsidiary of CreditAccess India N.V., a Netherlands-based holding company. The company commands a 6.9% market share in the overall Indian microfinance industry, making it the single-largest player in the segment. As of the close of 1 June 2026, the stock traded at ₹1,314 per share on the NSE, reflecting a market capitalization of ₹21,087 crore.

This report provides a comprehensive analysis of CreditAccess Grameen's financial performance, peer positioning, balance sheet strength, quarterly trends, shareholding patterns, and investment outlook based on the latest available data.


Business Model and Key Strengths

CreditAccess Grameen's business model is centered around group lending to women borrowers in underserved geographies. The JLG model, pioneered by Grameen Bank in Bangladesh, involves small groups of women guaranteeing each other's loans, creating a self-enforcing repayment mechanism. This model has proven remarkably effective in reaching financially excluded populations while maintaining manageable credit risk.

Key business highlights include:

  • Market Leadership: The company holds a 6.9% market share in India's microfinance sector, the highest among all MFI-NBFCs in the country.
  • Rural and Semi-Urban Focus: The loan book is concentrated in South and West India, with a strong presence in states like Karnataka, Tamil Nadu, Maharashtra, Madhya Pradesh, and Uttar Pradesh.
  • Women-Centric Lending: Virtually all borrowers are women organized in Joint Liability Groups, serving low-income households with limited access to formal banking.
  • Diversified Financial Services: Beyond core microfinance, the company uses its distribution network to cross-sell other financial products, including small business loans, two-wheeler loans, and housing loans.
  • Part of a Global Group: Being part of CreditAccess India N.V. (Netherlands) provides access to international best practices in microfinance, governance frameworks, and capital market expertise.
  • Part of key indices: The stock is a constituent of BSE 500, Nifty 500, Nifty Smallcap 100, BSE Financial Services, and BSE 250 SmallCap Index.

Current Valuation Snapshot

As of 1 June 2026, the key valuation metrics for CreditAccess Grameen are:

MetricValue
Current Price₹1,314
Market Capitalization₹21,087 crore
52-Week High / Low₹1,568 / ₹1,100
Stock P/E Ratio27.1x
Price-to-Book Value2.68x (Book Value: ₹490/share)
Dividend Yield0.00%
ROCE9.96%
ROE10.5%
Face Value₹10.0

The stock is currently trading 16.2% below its 52-week high of ₹1,568 and 19.5% above its 52-week low of ₹1,100, indicating a mid-range positioning within its annual trading band. The P/E ratio of 27.1x is elevated relative to the peer median of 22.25x, but this premium reflects the company's market leadership, superior asset quality history, and scale advantages.


Annual Financial Performance (Profit & Loss)

CreditAccess Grameen has demonstrated strong revenue and profit growth over the past several years, though recent performance has been affected by asset quality normalization in the microfinance sector.

Revenue Growth

YearRevenue (₹ Cr)YoY Growth
Mar 20191,282
Mar 20201,70432.9%
Mar 20212,46144.4%
Mar 20222,6698.5%
Mar 20233,48730.6%
Mar 20245,16748.1%
Mar 20255,75211.3%
Mar 20266,0595.3%

Revenue has grown at a compounded annual growth rate (CAGR) of approximately 20% over 5 years and 20% over 3 years, though the TTM growth has moderated to 5%, reflecting the cyclical slowdown in the microfinance industry.

Profitability Trajectory

YearNet Profit (₹ Cr)EPS (₹)Financing Margin
Mar 201932222.4139%
Mar 202033523.1728%
Mar 20211318.619%
Mar 202235322.6517%
Mar 202382652.8731%
Mar 20241,44690.7238%
Mar 202553133.2713%
Mar 202677848.5418%

The profit trajectory tells a story of significant cyclicality. After a sharp decline in FY21 (COVID-19 impact, net profit plunging to ₹131 crore with EPS of just ₹8.61), the company staged a remarkable recovery, with net profit peaking at ₹1,446 crore in FY24 (EPS: ₹90.72). However, FY25 saw a significant correction to ₹531 crore (EPS: ₹33.27) as the microfinance sector faced widespread asset quality stress.

The FY26 results show a strong recovery, with net profit rising to ₹778 crore (EPS: ₹48.54), up 46.5% YoY, indicating that the worst of the asset quality cycle may be behind the company.

Key P&L observations:

  • 5-Year Profit CAGR: 42% (from FY19 to FY26, benefiting from the low base of FY21)
  • 3-Year Profit CAGR: -2% (reflecting the peak-to-trough decline from FY24 to FY25)
  • TTM Profit Growth: 46% (strong recovery signal)
  • Interest costs in FY26 stood at ₹1,899 crore, representing 31.3% of revenue
  • Operating expenses were ₹3,067 crore in FY26, indicating a cost-to-income ratio that remains under pressure
  • Financing margin improved from 13% in FY25 to 18% in FY26, signaling better operational efficiency
  • Tax rate has stabilized around 25% in recent years

The quarterly data reveals the granular trajectory of the company's recovery from the microfinance sector stress.

Quarterly Revenue and Profit Trend

QuarterRevenue (₹ Cr)Net Profit (₹ Cr)EPS (₹)Financing Margin
Mar 20231,06529718.9838%
Jun 20231,17034822.3041%
Sep 20231,24734721.8138%
Dec 20231,29235322.2038%
Mar 20241,45739724.9137%
Jun 20241,51239824.9536%
Sep 20241,45318611.6718%
Dec 20241,380-100-6.24-8%
Mar 20251,407472.965%
Jun 20251,463603.777%
Sep 20251,5081267.8712%
Dec 20251,49025215.7524%
Mar 20261,59734021.2029%

The quarterly progression tells a compelling recovery story:

  • Q3 FY25 (Dec 2024) was the trough, with the company reporting a net loss of ₹100 crore and a negative financing margin of -8%, driven by elevated provisioning on stressed microfinance loans.
  • From that nadir, each subsequent quarter has shown improvement: ₹47 crore profit in Q4 FY25, ₹60 crore in Q1 FY26, ₹126 crore in Q2 FY26, ₹252 crore in Q3 FY26, and ₹340 crore in Q4 FY26.
  • Q4 FY26 revenue of ₹1,597 crore is the highest quarterly revenue ever reported by the company.
  • Financing margin has expanded from -8% in Dec 2024 to 29% in Mar 2026, indicating a return to normalized profitability levels.

Asset quality is the most critical metric for any MFI, and CreditAccess Grameen's trajectory here is noteworthy:

QuarterGross NPA %Net NPA %
Mar 20231.21%
Jun 20230.89%0.27%
Sep 20230.77%0.24%
Dec 20230.97%0.29%
Mar 20241.18%0.35%
Jun 20241.46%0.45%
Sep 20242.44%0.76%
Dec 20243.99%1.28%
Mar 20254.76%1.73%
Jun 20254.70%1.78%
Sep 20253.65%1.26%
Dec 20254.04%1.36%

Gross NPAs surged from a low of 0.77% in Sep 2023 to a peak of 4.76% in Mar 2025, before declining to 3.65% in Sep 2025. The Dec 2025 quarter saw a marginal uptick to 4.04%, suggesting that while the worst may be over, normalization will take time. Net NPAs peaked at 1.78% in Jun 2025 and have since moderated to 1.36%.


Balance Sheet Strength

Assets and Liabilities Overview

YearTotal Assets (₹ Cr)Borrowings (₹ Cr)Reserves (₹ Cr)Equity (₹ Cr)
Mar 20197,3574,8672,222144
Mar 202012,5909,5402,590144
Mar 202115,06010,9413,536156
Mar 202217,48212,9214,011156
Mar 202321,85816,3124,948159
Mar 202428,87121,8416,411159
Mar 202527,80220,4466,796160
Mar 202631,93023,6417,682160

Key balance sheet observations:

  • Total assets have grown from ₹7,357 crore in FY19 to ₹31,930 crore in FY26, a 4.3x increase over seven years.
  • Borrowings stand at ₹23,641 crore in FY26, growing from ₹20,446 crore in FY25, indicating the company is re-leveraging as it resumes loan book growth.
  • Reserves have expanded from ₹2,222 crore to ₹7,682 crore, reflecting accumulated profits over the years.
  • Equity capital has remained stable at ₹160 crore, with minimal dilution.
  • Debt-to-equity ratio (Borrowings / [Equity + Reserves]) stands at approximately 2.97x in FY26, typical for an NBFC-MFI.
  • Fixed assets have remained modest at ₹588 crore in FY26, reflecting the asset-light nature of the microfinance business.
  • Other assets (primarily the loan book) constitute the bulk of the balance sheet at ₹30,267 crore in FY26.

Book Value Analysis

  • Book value per share stands at ₹490 as of the latest data.
  • At the current price of ₹1,314, the stock trades at a P/B ratio of 2.68x.
  • While this is a premium to book value, it is reasonable for a market-leading MFI with a strong franchise, though it is on the higher side relative to peers in the current stressed environment.

Cash Flow Analysis

YearCFO (₹ Cr)FCF (₹ Cr)CFF (₹ Cr)Net Cash Flow (₹ Cr)
Mar 2019-1,378-1,3961,829444
Mar 2020-2,228-2,2502,92154
Mar 2021-455-4692,1461,715
Mar 2022-2,713-2,7411,967-780
Mar 2023-3,290-3,3073,365-239
Mar 2024-4,734-4,7545,494-234
Mar 20251,1251,092-1,669164
Mar 2026-2,770-2,7872,751-120

Cash flow from operations (CFO) for an NBFC-MFI is inherently volatile because loan disbursements and collections directly impact operating cash flow. A growing loan book typically results in negative CFO as new loan disbursements exceed collections. The positive CFO of ₹1,125 crore in FY25 was an anomaly caused by reduced loan disbursement during the stress period, while the return to negative CFO of ₹2,770 crore in FY26 indicates the company has resumed active lending.

The CFO-to-Operating Profit ratio has been volatile, ranging from -194% (FY20) to 54% (FY25), with FY26 at -86%. This pattern is normal for a growing MFI and should not be interpreted the same way negative CFO would be for a manufacturing company.


Profitability Ratios and Growth Metrics

Return on Equity (ROE) Trend

YearROE %
Mar 201914%
Mar 202013%
Mar 20214%
Mar 20229%
Mar 202318%
Mar 202425%
Mar 20258%
Mar 202611%

ROE peaked at 25% in FY24 before declining sharply to 8% in FY25 and recovering to 11% in FY26. The 5-year average ROE is 14% and the 3-year average is 14%. While the current 11% is below historical averages, it is trending upward and should improve further as asset quality normalizes and profitability recovers.

Compounded Growth Rates

Metric5-Year CAGR3-Year CAGRTTM
Revenue Growth20%20%5%
Profit Growth42%-2%46%
Stock Price CAGR16%2%15%

Peer Comparison

CreditAccess Grameen operates in the Microfinance Institutions sub-sector within the broader Financial Services industry. Here is how it stacks up against its listed peers:

CompanyCMP (₹)P/EMkt Cap (₹ Cr)NP Qtr (₹ Cr)Qtr Profit Var %Sales Qtr (₹ Cr)ROCE %
CreditAcc. Gram.1,313.9027.1221,087339.55619.23%1,597.279.96%
Muthoot Microfin174.0717.372,95871.12117.73%631.819.30%
Fusion Finance171.40200.452,776114.19169.39%424.025.92%
Satin Creditcare221.517.332,435162.04640.16%919.5013.84%
Spandana Sphoorty248.551,9785.49101.34%238.44-5.04%
Median (5 Co.)221.5122.252,776114.19169.39%631.819.30%

Key peer comparison takeaways:

  • CreditAccess Grameen is by far the largest MFI in India by market capitalization at ₹21,087 crore, which is 7.6x larger than the second-largest peer, Muthoot Microfin (₹2,958 crore).
  • The company's quarterly revenue of ₹1,597 crore is the highest in the peer group, reflecting its dominant market position.
  • Quarterly profit growth of 619% YoY is the strongest among peers (excluding Satin Creditcare's 640%), driven by the low base of the stress-impacted quarter.
  • The P/E ratio of 27.12x is at a premium to the peer median of 22.25x, but this is justified by the company's scale, brand, and market leadership.
  • ROCE of 9.96% is above the peer median of 9.30% but below Satin Creditcare's 13.84%.
  • Spandana Sphoorty remains the weakest peer with a negative ROCE of -5.04% and barely any quarterly profit (₹5.49 crore).
  • Fusion Finance trades at an extremely elevated P/E of 200.45x due to depressed earnings, while Satin Creditcare appears cheapest at 7.33x but has its own challenges.

Shareholding Pattern Analysis

Current Shareholding (March 2026 Quarter)

CategoryHolding %
Promoters66.24%
FIIs12.94%
DIIs12.59%
Public / Others8.23%
Total Shareholders83,884

Promoter Holding Trend

PeriodPromoter %FII %DII %Public %No. of Shareholders
Mar 201980.19%7.58%5.54%6.69%44,866
Mar 202079.94%5.59%8.66%5.80%41,744
Mar 202173.99%10.14%9.02%6.86%38,456
Mar 202273.85%8.24%10.94%6.97%34,568
Mar 202373.68%9.67%12.27%4.38%41,979
Mar 202466.58%11.65%15.76%6.01%69,824
Mar 202566.43%11.38%12.67%9.50%1,19,819
Mar 202666.24%12.94%12.59%8.23%83,884

Key shareholding observations:

  • Promoter holding has declined by 13.95 percentage points over 7 years, from 80.19% in Mar 2019 to 66.24% in Mar 2026. This is partly due to the parent company (CreditAccess India N.V.) selling stakes through offers for sale (OFS) to meet minimum public shareholding norms.
  • FII holding has nearly doubled from 7.58% to 12.94%, reflecting growing international interest in India's microfinance sector.
  • DII holding peaked at 15.76% in Mar 2024 and has since moderated to 12.59%.
  • Public shareholding reached a peak of 9.50% in Mar 2025 (when the stock was under pressure) and has moderated to 8.23%.
  • Number of shareholders peaked at 1,19,819 in Mar 2025 (during the stress period when retail interest surged) and has since normalized to 83,884 in Mar 2026.
  • The quarterly shareholder trend from Jun 2023 to Mar 2026 shows promoter holding declining steadily from 66.77% to 66.24%, while FII holding increased from 9.55% to 12.94%.

Pros and Cons Assessment

Cons (Areas of Concern)

Based on the latest data, the following areas of concern are highlighted:

  1. Premium Valuation: The stock trades at 2.68 times its book value, which is elevated for a microfinance company, particularly one that has experienced recent asset quality stress.

  2. No Dividend Payout: Despite reporting repeated profits, the company has not paid dividends (Dividend Yield: 0.00%). Over the last 3 years, the dividend payout ratio has been just 3.67% of profits, with only FY24 seeing a 11% payout.

  3. Low Interest Coverage: The company has a low interest coverage ratio, which is a concern given the interest-rate-sensitive nature of its business model.

  4. Moderate ROE: The 3-year average ROE of 13.8% (or 14% by another measure) is respectable but not exceptional. The latest year's ROE of 11% is below the company's own historical peaks of 25%.

  5. Declining Promoter Holding: Promoter holding has decreased by 7.44% over the last 3 years (from 73.68% in Mar 2023 to 66.24% in Mar 2026), which is a concern, though largely driven by regulatory requirements rather than loss of confidence.

  6. Sector-Wide Asset Quality Stress: The microfinance sector is undergoing a cyclical stress phase, with GNPA levels rising across the industry. CreditAccess Grameen's GNPA of 4.04% (Dec 2025) remains elevated compared to the 0.77% low in Sep 2023.

Strengths

Despite the concerns, the company has several compelling strengths:

  1. India's Largest MFI with 6.9% market share in the microfinance industry.
  2. Strong brand and distribution network across South and West India.
  3. Improving quarterly trajectory — from a loss of ₹100 crore in Dec 2024 to a profit of ₹340 crore in Mar 2026.
  4. Revenue diversification through multiple financial products beyond core microfinance.
  5. Institutional backing from a Netherlands-based parent company with global microfinance expertise.
  6. Part of key indices including Nifty 500, BSE 500, and Nifty Smallcap 100.

Investment Thesis

Bull Case

The bull case for CreditAccess Grameen rests on several factors:

  1. Earnings Recovery: The company has demonstrated a clear V-shaped recovery in profitability, with Q4 FY26 profit of ₹340 crore approaching the ₹397-398 crore quarterly profits seen during the peak in FY24. If this trajectory continues, annualized FY27 profits could reach ₹1,200-1,400 crore, implying a forward P/E of 15-17.5x — attractive for a market leader.

  2. Asset Quality Normalization: While GNPA levels remain elevated at 4.04%, the trend from the peak of 4.76% (Mar 2025) suggests that credit costs have peaked and provisioning pressures will ease.

  3. Revenue Growth Resumption: Q4 FY26 revenue of ₹1,597 crore (the highest ever) signals that the company is returning to growth mode. The microfinance sector's long-term structural growth story remains intact, with significant unbanked population still to be served.

  4. Market Consolidation: During stress periods, weaker players (like Spandana Sphoorty with a negative ROCE) lose market share, while stronger players like CreditAccess Grameen gain. This consolidation benefit should become visible over the next 2-3 years.

  5. Reasonable Valuation at Current Levels: At ₹1,314 (16% below the 52-week high), the stock offers a reasonable entry point for long-term investors, especially if earnings continue to recover.

Bear Case

  1. Microfinance Sector Risk: The sector is inherently cyclical and exposed to policy risk (e.g., RBI regulations on interest rates, lending caps, and customer protection). Any further tightening could delay recovery.

  2. Sustained High NPAs: If GNPA levels stabilize around 4% rather than normalizing to the 1-2% range seen historically, profitability will remain structurally lower.

  3. Competition and Margin Pressure: Increasing competition from banks entering microfinance and fintech players could compress margins over time.

  4. Promoter Exit Risk: The continued decline in promoter holding (from 80% to 66% over 7 years) raises questions about the long-term commitment of the parent company.

  5. Macro Sensitivity: Microfinance borrowers are among the most economically vulnerable segments. Any macroeconomic shock (drought, pandemic, rural distress) could trigger another cycle of defaults.

Valuation Considerations

At the current market price of ₹1,314:

  • Trailing P/E: 27.1x based on FY26 EPS of ₹48.54
  • Forward P/E (estimated FY27): If the company earns ₹70-80 EPS in FY27, the forward P/E would be 16.4-18.8x
  • P/B Ratio: 2.68x on a book value of ₹490/share
  • Market Cap / AUM: Approximately 0.66x based on estimated AUM of ~₹32,000 crore

Conclusion

CreditAccess Grameen Ltd stands at an important inflection point. After enduring a severe asset quality cycle that saw the company report its first-ever quarterly loss in Dec 2024 (₹100 crore), the recovery has been swift and decisive. Q4 FY26 reported a net profit of ₹340 crore with a financing margin of 29%, approaching pre-stress levels.

As India's largest microfinance institution with a 6.9% market share, a ₹21,087 crore market capitalization, and a presence in the Nifty 500 and BSE 500 indices, CreditAccess Grameen offers exposure to India's financial inclusion story at a stage when the worst of the credit cycle appears to be behind it.

However, investors must weigh this recovery potential against the structural risks inherent in microfinance lending — cyclicality, regulatory exposure, and the vulnerability of the borrower base to economic shocks. The stock's P/B of 2.68x and trailing P/E of 27.1x are not cheap in absolute terms, but if the company can sustain its Q4 FY26 run-rate and normalize ROE to 15-18%, the current valuation may prove reasonable on a 2-3 year horizon.

For investors with a medium to long-term perspective and an appetite for microfinance sector exposure, CreditAccess Grameen represents a high-quality play on India's rural credit market, backed by a proven management team, a strong brand, and the financial muscle of its Netherlands-based parent. The key risk remains the sustainability of the asset quality recovery and the pace at which profitability normalizes to historical levels.


⚠ Disclaimer

This content is for educational purposes only and does not constitute investment advice. We are not SEBI registered. Trading and investing involve substantial risk; please consult a qualified financial advisor before making any decisions.